A new trading day began on Tuesday, with Ocular Therapeutix Inc (NASDAQ: OCUL) stock price down -1.90% from the previous day of trading, before settling in for the closing price of $8.93. OCUL’s price has ranged from $2.00 to $11.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 121.20% over the last five years. Meanwhile, its annual earnings per share averaged -16.21%. With a float of $135.52 million, this company’s outstanding shares have now reached $155.92 million.
The firm has a total of 267 workers. Let’s measure their productivity. In terms of profitability, gross margin is 90.81%, operating margin of -187.94%, and the pretax margin is -227.16%.
Ocular Therapeutix Inc (OCUL) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ocular Therapeutix Inc is 13.09%, while institutional ownership is 76.73%. The most recent insider transaction that took place on Aug 23 ’24, was worth 16,525. In this transaction Chief Strategy Officer of this company sold 1,832 shares at a rate of $9.02, taking the stock ownership to the 176,194 shares. Before that another transaction happened on Aug 23 ’24, when Company’s See Remarks sold 20,880 for $9.02, making the entire transaction worth $188,338. This insider now owns 812,473 shares in total.
Ocular Therapeutix Inc (OCUL) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.01 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.21% per share during the next fiscal year.
Ocular Therapeutix Inc (NASDAQ: OCUL) Trading Performance Indicators
Here are Ocular Therapeutix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Ocular Therapeutix Inc (OCUL)
Analysing the last 5-days average volume posted by the [Ocular Therapeutix Inc, OCUL], we can find that recorded value of 0.87 million was lower than the volume posted last year of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 82.72%. Additionally, its Average True Range was 0.42.
During the past 100 days, Ocular Therapeutix Inc’s (OCUL) raw stochastic average was set at 88.18%, which indicates a significant increase from 68.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.18% in the past 14 days, which was lower than the 67.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.30, while its 200-day Moving Average is $6.75. Now, the first resistance to watch is $8.96. This is followed by the second major resistance level at $9.17. The third major resistance level sits at $9.30. If the price goes on to break the first support level at $8.62, it is likely to go to the next support level at $8.49. Should the price break the second support level, the third support level stands at $8.28.
Ocular Therapeutix Inc (NASDAQ: OCUL) Key Stats
With a market capitalization of 1.37 billion, the company has a total of 154,889K Shares Outstanding. Currently, annual sales are 58,440 K while annual income is -80,740 K. The company’s previous quarter sales were 16,440 K while its latest quarter income was -43,780 K.
